Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of Tuesday, October 6, 2026.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
Latigo Biotherapeutics Inc.
Market Cap
$1.01B
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$997.80M
Return on Invested Capital (ROIC)
52.81%
TTM Avg
-75.45%
3Y Avg
-63.24%
5Y Avg
-50.31%
Market Cap
$998.93M
Return on Invested Capital (ROIC)
-27.51%
TTM Avg
-21.69%
3Y Avg
-25.73%
5Y Avg
-26.71%
Market Cap
$997.28M
Return on Invested Capital (ROIC)
-16.54%
TTM Avg
-24.45%
3Y Avg
-23.43%
5Y Avg
-23.43%
Market Cap
$1.00B
Return on Invested Capital (ROIC)
-28.14%
TTM Avg
-132.46%
3Y Avg
-76.17%
5Y Avg
-76.17%
Market Cap
$990.99M
Return on Invested Capital (ROIC)
1.35%
TTM Avg
-1.75%
3Y Avg
1.09%
5Y Avg
1.96%
Market Cap
$1.02B
Return on Invested Capital (ROIC)
0.86%
TTM Avg
2.66%
3Y Avg
2.26%
5Y Avg
2.26%
Market Cap
$1.03B
Return on Invested Capital (ROIC)
20.01%
TTM Avg
1.42%
3Y Avg
2.77%
5Y Avg
3.34%
Market Cap
$1.04B
Return on Invested Capital (ROIC)
-53.36%
TTM Avg
-19.72%
3Y Avg
-15.42%
5Y Avg
-34.93%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Latigo Biotherapeutics Inc. (LTGO) | $1.01B | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $997.80M | 52.81% | -75.45% | -63.24% | -50.31% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $998.93M | -27.51% | -21.69% | -25.73% | -26.71% |
| Aktis Oncology, Inc. (AKTS)vs › | $997.28M | -16.54% | -24.45% | -23.43% | -23.43% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $1.00B | -28.14% | -132.46% | -76.17% | -76.17% |
| Pacira BioSciences, Inc. (PCRX)vs › | $990.99M | 1.35% | -1.75% | 1.09% | 1.96% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 0.86% | 2.66% | 2.26% | 2.26% |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 20.01% | 1.42% | 2.77% | 3.34% |
| Immatics N.V. (IMTX)vs › | $1.04B | -53.36% | -19.72% | -15.42% | -34.93% |
| Kura Oncology, Inc. (KURA)vs › | $963.61M | -67.13% | -38.55% | -37.38% | -31.65% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
